Results 221 to 230 of about 9,686,810 (338)

Impact of Newborn Screening on Survival and Developmental Outcome in Classic Isovaleric Aciduria: A Meta-Analysis. [PDF]

J Inherit Metab Dis
Reischl-Hajiabadi AT, Garbade SF, Gleich F, Schnabel-Besson E, Posset R, Zielonka M, Hoffmann GF, Kölker S, Mütze U.   +8 more
europepmc   +1 more source

Easing the Transfer of Students from College to University Programs: How Can Learning Outcomes Help?

, 1969
Irene Carter, James P. Coyle, Donald R. Leslie   +2 more
openalex   +2 more sources

Predicting the Outcome [PDF]

Journal of the Royal Society of Medicine, 1987
Bryan Jennett, G Teasdale
openaire   +3 more sources

Dose‐dependent induction of epithelial‐mesenchymal transition in 3D melanoma models by non‐thermal plasma treatment

Molecular Oncology, EarlyView.
Non‐thermal plasma treatment of melanoma cells induced epithelial‐mesenchymal transition (EMT) in a dose‐dependent fashion. This report highlights the critical need to further investigate potential adverse effects of non‐thermal plasma for cancer therapy and to optimize treatment parameters for clinical translation. Despite the promising results of non‐
Eline Biscop, Edgar Cardenas De La Hoz, Hanne Verswyvel, Joey De Backer, Ho Wa Lau, Angela Privat‐Maldonado, Wim Vanden Berghe, Steve Vanlanduit, Evelien Smits, Annemie Bogaerts, Abraham Lin   +10 more
wiley   +1 more source

Patient-Reported Outcome Measures to Determine Sleep Problems in Adults With Chronic Kidney Disease: A Systematic Review. [PDF]

J Ren Care
Chiang WS, Purtell L, Corones-Watkins K, Bonner A.   +3 more
europepmc   +1 more source

Can living donor liver transplantation offer similar outcomes to deceased donor liver transplantation using expanded selection criteria for hepatocellular carcinoma?

, 1969
Liping Chen, Chuan Li, Tian-Fu Wen, Lu-Nan Yan, Bo Li, Jiayin Yang   +5 more
openalex   +1 more source

Molecular imaging predicts trastuzumab‐deruxtecan (T‐DXd) response in head and neck cancer xenograft models

Molecular Oncology, EarlyView.
Trastuzumab‐deruxtecan, a HER2‐targeting antibody‐drug conjugate, shows promising antitumor activity in head and neck squamous cell carcinoma with low HER2 expression. In vitro and in vivo studies demonstrated dose‐dependent cell death and tumor growth reduction in low HER2‐expressing cell lines, which correlated with drug accumulation measured using a
Abdullah Bin Naveed, Lucas Mani, Muhammad Bilal Mirza, Ashtyn McAdoo, Takahito Kondo, Hidenori Tanaka, Nicole Meeks, Eben Rosenthal, Marisa Hom   +8 more
wiley   +1 more source

Interpreting Quadriceps Strength Thresholds for Patients Following ACL-Reconstruction: A Clinical Commentary. [PDF]

Int J Sports Phys Ther
Bodkin S, Bennion D, Pales-Taylor M, Teramoto M, Maak T.   +4 more
europepmc   +1 more source

Genomics‐led approach to drug testing in models of undifferentiated pleomorphic sarcoma

Molecular Oncology, EarlyView.
GA text Genomic data from undifferentiated pleomorphic sarcoma patients and preclinical models were used to inform a targeted drug screen. Selected compounds were tested in 2D and 3D cultures of UPS cell lines. A combination of trametinib and infigratinib was synergistic in the majority of UPS cell lines tested, which was further confirmed in an ex ...
Piotr J. Manasterski, Molly R. Danks, John P. Thomson, Morwenna Muir, Martin Lee, John C. Dawson, Ana T. Amaral, Juan Diaz‐Martin, David S. Moura, Javier Martin‐Broto, Ali Alsaadi, Donald M. Salter, Ailsa J. Oswald, Graeme Grimes, Larry Hayward, Ted R. Hupp, Karen Sisley, Paul H. Huang, Neil O. Carragher, Valerie G. Brunton   +19 more
wiley   +1 more source

Incidence and risk factors of extremely poor functional outcome after burr-hole evacuation of chronic subdural hematoma in octogenarians and nonagenarians- a retrospective cohort analysis. [PDF]

BMC Anesthesiol
Zarour S, Rajmilevich I, Zohar N, Agur R, Bergman L, Weiss Y, Goren O, Matot I, Cohen B.   +8 more
europepmc   +1 more source